Patients undergoing chemotherapy should discuss the use of L-theanine with their physicians because most purported effects are not based on clinical trials, and epigallocatechin-3-gallate (EGCG) in green tea reduces activity of the chemotherapy drug bortezomib
Business Type Manufacturer Payment Mode Telegraphic Transfer (T/T) Related Products Explore Related Categories More Products From This Seller Recommended Products Compare With Similar Products Application Other Other, Industrial, Pharmaceutical Payment Terms Cash Against Delivery (CAD), Cash on Delivery (COD), Others, Cash in Advance (CID), Cash Advance (CA) Cash on Delivery (COD), Cash Against Delivery (CAD), Cash in Advance (CID), Cheque, Cash Advance (CA) Telegraphic Transfer (T/T), Cash in Advance (CID), Cheque, Cash Advance (CA) Main Domestic Market All India Himachal Pradesh, Andaman and Nicobar Islands, , South India, East India, Andhra Pradesh, Assam, Arunachal Pradesh, Bihar, Chandigarh, Goa, Haryana, Jammu and Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Manipur, Punjab, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Nagaland, Pondicherry, Uttarakhand, Daman and Diu, Dadra and Nagar Haveli, Lakshadweep, Uttar Pradesh, Gujarat, Delhi, Rajasthan, Karnataka, North India, Kerala, Central India, Odisha, West India, Chhattisgarh, All India All India Main Export Market(s) Australia, South America, Eastern Europe, Middle East, Western Europe, Africa, Central America, Asia, North America Australia, North America, Eastern Europe, Middle East, Western Europe, Africa, Central America, South America, Asia Certifications GPCB Certificate ISO: 9001
Athletes and Bodybuilders For those seeking to optimize performance , Ipamorelin offers powerful benefits: Enhances lean muscle growth and recovery Increases protein synthesis Reduces catabolic breakdown during intense training Supports fat loss without muscle loss The muscle-preserving and recovery-enhancing effects make Ipamorelin ideal during both bulking and cutting phases of training
Nat Rev Endocrinol 22 , 153165 (2026)
